Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Brow Enhancement Study

This study has been completed.
Information provided by (Responsible Party):
Derek H. Jones, M.D., Skin Care and Laser Physicians of Beverly Hills Identifier:
First received: March 2, 2011
Last updated: January 3, 2013
Last verified: January 2013
Investigation into brow aesthetics using Botox in Conjunction with Juvederm XC as evaluated by patient satisfaction

Condition Intervention Phase
Brow Ptosis
Device: Juvederm XC
Drug: Botox
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Investigation Into Brow Aesthetics Using Botox in Conjunction With Juvederm Ultra XC as Evaluated by Patient Satisfaction

Resource links provided by NLM:

Further study details as provided by Skin Care and Laser Physicians of Beverly Hills:

Primary Outcome Measures:
  • Participant satisfaction with combined injection with Botox and Juvederm XC [ Time Frame: 5 months ]

Enrollment: 30
Study Start Date: March 2011
Study Completion Date: October 2011
Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Juvederm XC
Juvederm XC
Device: Juvederm XC
Active Comparator: Botox
Medication used to block neuromuscular transmission
Drug: Botox
26 units dosed one time


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Men and women

Exclusion Criteria:

  • Persons who have not had Botox for months.
  • Women who are pregnant, breastfeeding, or trying to get pregnant.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01308593

United States, California
Skin Care and Laser Physicians of Beverly Hills
Los Angeles, California, United States, 90069
Sponsors and Collaborators
Skin Care and Laser Physicians of Beverly Hills
  More Information

Responsible Party: Derek H. Jones, M.D., Principal Investigator, Skin Care and Laser Physicians of Beverly Hills Identifier: NCT01308593     History of Changes
Other Study ID Numbers: Brow Study 25856/1
Study First Received: March 2, 2011
Last Updated: January 3, 2013

Additional relevant MeSH terms:
Acetylcholine Release Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Cholinergic Agents
Neurotransmitter Agents
Physiological Effects of Drugs processed this record on May 22, 2017